Semaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...

Until recently, several glucagon-like peptide-1 (GLP-1) injections were in shortage. During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan ...

More people are "microdosing" GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Here's what to know and what to be cautious of, according to doctors.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between ...

Embla today announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that ...

The study in almost 3,000 patients, all from Denmark, found that patients were able to meet their weight-loss goals of a 0.5% or greater reduction in weight per week with less than half that dose ...

Combining GLP-1 micro-dosing with expert psychology-based coaching, Embla delivers an average 16.7% weight loss in 12 months, using 66% less medication. That means better outcomes, fewer side ...

Combining GLP-1 micro-dosing with expert psychology-based coaching, Embla delivers an average 16.7% weight loss in 12 months, using 66% less medication. That means better outcomes, ...